Views 365
Citations 0
Invited Commentary
September 2016

30-Day Readmission Rate—A Blunt Instrument That Needs Honing

Author Affiliations
  • 1Department of Surgery, Harbor–University of California, Los Angeles Medical Center, Torrance

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Surg. 2016;151(9):861. doi:10.1001/jamasurg.2016.1229

Estimated to cost Medicare $17 billion annually, hospital readmissions represent a potential cost-savings target. Unplanned readmissions may also measure hospital and medical quality because these events are presumed to demonstrate a gap in sound clinical care or discharge planning. To address this issue, the Centers for Medicare and Medicaid Services established the Medicare Hospital Readmissions Reduction Program to decrease readmissions and publicly report 30-day readmission rates for selected admission diagnoses and procedures.1 The number of reportable surgical conditions is expected to increase in the future.2 The Centers for Medicare and Medicaid Services has also begun penalizing hospitals with a higher than expected 30-day readmission rate. This program and these penalties rely on the assumption that 30-day readmissions indicate hospital and surgical quality.

First Page Preview View Large
First page PDF preview
First page PDF preview